MQS Management’s Bristol-Myers Squibb BMY Stock Holding History

MQS Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	+4,034	New	+$232K	0.28%	192
2025 Q4	–	Sell	-9,349	Closed	-$422K	–	428
2025 Q3	$422K	Buy	9,349 +597	+7%	+$27.9K	0.25%	163
2025 Q2	$405K	Buy	+8,752	New	+$430K	0.22%	179
2024 Q3	–	Sell	-9,821	Closed	-$408K	–	458
2024 Q2	$408K	Buy	+9,821	New	+$439K	0.25%	163
2024 Q1	–	Sell	-13,533	Closed	-$694K	–	465
2023 Q4	$694K	Sell	13,533 -479	-3%	-$25.1K	0.39%	59
2023 Q3	$813K	Buy	14,012 +4,742	+51%	+$291K	0.5%	27
2023 Q2	$593K	Buy	9,270 +820	+10%	+$55K	0.4%	54
2023 Q1	$586K	Sell	8,450 -1,859	-18%	-$131K	0.38%	66
2022 Q4	$742K	Buy	+10,309	New	+$777K	0.5%	37
2022 Q3	–	Sell	-2,672	Closed	-$206K	–	423
2022 Q2	$206K	Sell	2,672 -1,321	-33%	-$101K	0.14%	318
2022 Q1	$292K	Sell	3,993 -5,041	-56%	-$338K	0.24%	201
2021 Q4	$563K	Buy	+9,034	New	+$530K	0.9%	13

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MQS Management's BMY Position: Q2 2026 in Review

MQS Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,034 shares worth $232K. The stake represents 0.28% of the portfolio and ranks #192 among its holdings. This is a return to the name: MQS Management previously reported a position in BMY as recently as Q3 2025.

MQS Management first reported a position in BMY in Q4 2021 and has held it in 12 quarters since. The position peaked at $813K in Q3 2023. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

MQS Management held 4,034 shares of Bristol-Myers Squibb worth $232K as of Q2 2026.
Bristol-Myers Squibb was a new MQS Management position in Q2 2026.
Bristol-Myers Squibb made up 0.28% of MQS Management's portfolio in Q2 2026, its #192 holding.
MQS Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 12 quarters since.
MQS Management's Bristol-Myers Squibb position peaked at $813K in Q3 2023.
2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.